A newly published study in the Annals of Internal Medicine has offered an analysis of the cost-effectiveness of “observation” as compared to immediate initial treatment for men diagnosed with low-risk, localized prostate cancer. This study by Hayes and her Harvard-based colleagues is relatively sophisticated and well conducted. It uses the data from the PIVOT trial […]Image may be NSFW.
Clik here to view.
Clik here to view.
